Added 21,000 customers in Q1, 27% growth year-over-year; enters Q2 with backlog of 23,000 retrofit customers Increased Revenue 26% and 32% year-over-year on a GAAP and non-GAAP basis, respectively Reported Q1 GAAP Net Loss of $51M, Adjusted EBITDA of $1M Invested in Wolf River Energy,…
Month: May 2023
PITTSBURGH, May 3, 2023 /PRNewswire/ — EQT Corporation (NYSE: EQT) (“EQT”) today announced that it has commenced a consent solicitation to amend the indenture (the “Indenture”) governing its outstanding 5.700% Senior Notes due 2028 (the “Notes”) to extend the Outside Date (as defined…
The advanced industrial analytics software helps customers extract valuable insights from operational data to improve performance, reduce downtime, and increase efficiency and productivity. SAN ANTONIO, May 3, 2023 /PRNewswire/ — Recently, Frost & Sullivan researched the industrial…
L’acquisition renforce l’offre de services à l’échelle mondiale sur le marché de l’impression de production FAIRFIELD, New Jersey, 3 mai 2023 /PRNewswire/ — Keypoint Intelligence, une société mondiale de données et de renseignements commerciaux pour l’industrie de l’impression numérique…
TAIPEH, 3. Mai 2023 /PRNewswire/ — EirGenix, Inc. (6589.TT) gab am28. April bekannt, dass es die klinische Studie der Phase 1 (EGC101) für sein zweites Brustkrebs-Biosimilar EG1206A in Europa abgeschlossen hat. Der Vergleich von EG1206A mit Perjeta® von Roche in den USA und der EU zeigt…
First Quarter 2023 Highlights: Total revenue of $143.4 million increased $75.5 million versus 2022 and $53.7 compared with 2019 Net loss available to stockholders of $0.4 million improved $42.6 million versus 2022 Adjusted EBITDA of $27.2 million increased $48.4 million versus 2022 and $5….
INGREZZA® (valbenazine) First Quarter Net Product Sales of $410 Million INGREZZA® (valbenazine) 2023 Net Product Sales Guidance Reiterated at $1.67 – $1.77 Billion SAN DIEGO, May 3, 2023 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for…
Kelly report discovers some employers are thriving while most struggle to build resilient organizations TROY, Mich., May 3, 2023 /PRNewswire/ — As employers around the world contend with the greatest workforce disruption in generations, a new global report released today by staffing…
Kelly report discovers some employers are thriving while most struggle to build resilient organizations LONDON, May 3, 2023 /PRNewswire/ — As employers around the world contend with the greatest workforce disruption in generations, a new global report released today by staffing leader…
WALTHAM, Mass., May 3, 2023 /PRNewswire/ — Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies for rare and prevalent devastating diseases, today announced that new…